Epinephrine potentiation of in viw stimuli reverses aspirin inhibition of platelet thrombos formation in stenosed canine coronary arteries

Thrombosis Research

Volumn 50, Issue 4, 1988, Pages 507-516

  Folts, John D ^a   Rowe, George G ^a  

^a University of Wisconsin Health   (United States)

Author keywords

aspirin; coronary thrombosis; epinephrine

Indexed keywords

ACETYLSALICYLIC ACID; ADRENALIN;

ANIMAL; ANIMAL CELL; ANIMAL EXPERIMENT; ARTERIOSCLEROSIS; BLOOD CLOTTING; CORONARY ARTERY DISEASE; DOG; INTRAVENOUS DRUG ADMINISTRATION; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION;

ANIMAL; ASPIRIN; BLOOD FLOW VELOCITY; BLOOD PRESSURE; CORONARY DISEASE; CORONARY THROMBOSIS; DOGS; EPINEPHRINE; FEMALE; HEART RATE; MALE; PLATELET AGGREGATION; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0023915665     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/0049-3848(88)90199-5     Document Type: Article

References (37)

1. Role of antithrombotic therapy in unstable angina myocardial infarction and sudden death
2. Clinical trials evaluating platelet-modifying drugs in patients with atherosclerotic cardiovascular disease and thrombosis
3. A perspective on platelet-suppressant drug treatment in coronary artery and cerebrovascular disease
4. Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina
5. Aspirin sulfinpyrazone or both in unstable angina
6. Platelet aggregation in partially obstructed vessels and their elimination with aspirin
7. Cyclical flow reductions in arterial blood flow in stenosed canine coronary arteries Vasospasm or platelet aggregation?
8. Experimental arterial platelet thrombosis, platelet inhibitors, and their possible clinical relevance
9. A perspective of coronary disease seen through the arteries of living man
10. Epinephrine induced platelet aggregation in mechanically stenosed dog coronary arteries occurring after aspirin administration
11. Norepinephrine and epinephrine release and adrenergic mediation of smoking-associated hemodynamic and metabolic events
12. Effect of beta blockade on plasma catecholamine levels during psychological and exercise stress
13. Electrocardiogram plasma catecholamines and lipids and their modification by cyprenolol when speaking before an audience
14. Effect of beta-blockade on circulatory catecholamines and dopamine beta hydroxylase activity during exercise in normal subjects
15. Modulation of carotid baroreflex responsiveness in man: effects of posture and propranolol
16. Excessive plasma dopamine increase at rest and during exercise after long-term beta adrenoreceptor blockade in hypertensive patients
17. Hypertension and propranolol therapy effect on blood pressure plasma catecholamines and platelet aggregation
18. Interactions of blood platelets with biogenic amines: uptake, stimulation and receptor binding
19. Platelet function in animals: Species specificities
20. Platelet-mediated thrombosis in stenosed canine coronary arteries inhibition by nicergoline a platelet-active alpha-adrenergic antagonist
21. Aggregation of blood platelets by adenosine diphosphate and its reversal
22. Factors influencing platelet function adhesion release and aggregation
23. Influence of epinephrine on the aggregation response of aspirin-treated platelets
24. Epinephrine reverses the inhibitory influence of aspirin on platelet-vessel wall interactions
25. Possible platelet thrombi formation in dogs and human femoral arteries
26. Aspirin for the prevention of coronary thrombosis current facts and perspectives
27. Experiences with aspirin (acetylsalicylic acid) in the nonspecific prophylaxis of coronary thrombosis
28. Synergistic inhibitory effects of aspirin and ethanol on epinephrine exacerbation of acute coronary thrombus formation in stenosed dog coronary arteries
29. Serial plasma catecbolamine response early in the course of clinical acute myocardial infarction Relationship to infarct extent and mortality
30. Neurohumerol control mechanisms in congestive heart failure
31. Plasma catecholamine response of coronary-prene subjects (Type A) to a specific challenge
32. The rabbit as a model for carotid artery stenosis, and periodic thrombosis
33. Antithnonbotic effect of a monoclonal antibody to the platelet glycoprotein IIb/IIIa receptor in an experimental animal model
34. Platelet thrombus formation in stenosed monkey carotid arteries, inhibited with aspirin, restored with epinephrine
35. Inhibition of canine platelet aggregation by barbiturates